insights_auto
Sebab BVNKF meningkat 3.33%?
Terokai Dengan Lebih Terperincichevron_right
BVNKF:OTCMKTS
Bavarian Nordic A/S
USD 33.66
arrow_upward
+3.33%(+1.08) 1H
29 Sep, 4:00:00 PTG GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk BVNKF...
Buka
USD 33.66
Tinggi
USD 33.66
Rendah
USD 33.66
Permodalan Pasaran
2.66B
Purata volum
133.00
Volum
100.00
tgi 52 mgu
USD 37.22
rdh 52 mgu
USD 27.69
Beta
1.46
Syer tertunggak
79.26J
Bilangan pekerja
2K
Buka
USD 33.66
Tinggi
USD 33.66
Rendah
USD 33.66
Permodalan Pasaran
2.66B
Purata volum
133.00
Volum
100.00
tgi 52 mgu
USD 37.22
rdh 52 mgu
USD 27.69
Beta
1.46
Syer tertunggak
79.26J
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Invezz
·
2 hari lalu
Micron boleh mengatasi Nvidia sebagai pendorong utama pertumbuhan keuntungan S&P 500
Simply Wall Street
·
21 minit lalu
Is NetApp (NTAP) Becoming More Central To AI Infrastructure With Novus?
Kalkine Media
·
1 jam lalu
BVF Partners Reveals 5.6% Ownership Stake in Stoke Therapeutics Inc. (NASDAQ:STOK)
Profil
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Perihal Bavarian Nordic A/S